Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc > This drop has no reason
View:
Post by Sylvain123 on Jul 21, 2020 12:46pm

This drop has no reason

Not easy to understand these cheap sales. I'm keeping this title, there's no reason for it to go down again.
Comment by Raddnar on Jul 21, 2020 1:49pm
There is a reason, and it’s simple. Heavy holders are selling their profits, to spark a mild panic sell to drop the price so they can buy more. See this with everything, especially penny stocks. This is how big money beats the little guy. Everyone knows stocks fluxiate, and AGNPF is more prone to that due to the market volatility and low share cost. If you believe in AGNPF, a 5/10% drop with ...more  
Comment by Raddnar on Jul 21, 2020 1:51pm
Edit: SHOULDN'T scare you.
Comment by GObabyGO1 on Jul 21, 2020 1:55pm
Classic sell the news 
Comment by luvhorses on Jul 21, 2020 2:26pm
As I stated many times here already...c.AGN will NOT  be moving UP anytime soon until: a)  $$$ from Health Canada; b)  Stats from the human trials can't get any simpler :))
Comment by Unicorn9000 on Jul 21, 2020 3:14pm
I bought more too. fully loaded scary great stuff
Comment by ceccinapup on Jul 21, 2020 3:30pm
i'm not in but still like to follow this just remember to take profits every now and then when you can better a little than nothing if it goes bad
Comment by Unicorn9000 on Jul 21, 2020 3:40pm
great advice and I usually do it most of the time but instead I average up this time. I think there is just too many good news we are waiting for before the end of July. Not to mention all these findings and reports of ifendropil being part of a Cure for Covid-19. can't miss the run.. .It will run like SONA did. scary good stuff
Comment by Davidtepperss62 on Jul 21, 2020 8:24pm
Je garde ce titre, il n'y a aucune raison pour qu'il redescende.   The stock markets have become a jungle of aggressive, corrupt sharks of Day Traders manipulators and speculators who buy and sell on the same day for a small profit because they don't want to get stuck with a short-term stock. is made a real casino of gamblers who have mental problems for quick money. This is ...more  
Comment by Davidtepperss62 on Jul 21, 2020 8:32pm
The brokerage houses Canaccord and Anonyme did the same thing on the PAS stock, which went from 0.27 ¢ to 0.45 ¢ and fell to 0.22 ¢ to go up a little today to 0.23 ¢ and 0.24 ¢. Can see very well that these two control and manipulate all the other brokerage houses, so they have to do like them and follow their aggressive movements.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities